<bill session="116" type="h" number="1103" updated="2020-07-13T18:59:19Z">
  <state datetime="2019-02-07">REFERRED</state>
  <status>
    <introduced datetime="2019-02-07"/>
  </status>
  <introduced datetime="2019-02-07"/>
  <titles>
    <title type="official" as="introduced">To amend the market name of genetically altered salmon in the United States, and for other purposes.</title>
    <title type="short" as="introduced">Genetically Engineered Salmon Labeling Act</title>
    <title type="short" as="introduced">Genetically Engineered Salmon Labeling Act</title>
    <title type="display">Genetically Engineered Salmon Labeling Act</title>
  </titles>
  <sponsor bioguide_id="Y000033"/>
  <cosponsors>
    <cosponsor bioguide_id="B001278" joined="2019-02-07"/>
    <cosponsor bioguide_id="D000191" joined="2019-02-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-07">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-02-07" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="282"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Environmental assessment, monitoring, research"/>
    <term name="Fishes"/>
    <term name="Food supply, safety, and labeling"/>
    <term name="Genetics"/>
    <term name="Marine and coastal resources, fisheries"/>
    <term name="Marketing and advertising"/>
    <term name="Seafood"/>
  </subjects>
  <amendments/>
  <summary date="2019-02-07T05:00:00Z" status="Introduced in House">Genetically Engineered Salmon Labeling Act

This bill requires the market name of genetically engineered (commonly called genetically modified or GMO) salmon to include Genetically Engineered or GE in front of the existing market name.

The Department of Health and Human Services must ensure that an independent scientific organization conducts a review of the environmental assessment carried out by the Food and Drug Administration in support of a new drug related to AquAdvantage Salmon.</summary>
  <committee-reports/>
</bill>
